SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2109151

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2109151

Healthcare LLM and Foundation Model Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Healthcare LLM and Foundation Model Market was valued at USD 2.4 billion in 2025 and is estimated to grow at a CAGR of 27.7% to reach USD 27.7 billion by 2035.

Healthcare LLM and Foundation Model Market - IMG1

Market expansion is being fueled by the rapid adoption of artificial intelligence across the healthcare ecosystem, where organizations are investing in advanced language and foundation models to improve operational efficiency, clinical accuracy, and patient outcomes. Rising demand for AI-enabled clinical documentation, virtual care platforms, intelligent patient engagement solutions, and advanced healthcare analytics is creating substantial opportunities for technology providers. The growing use of foundation models in life sciences research, precision medicine, and genomics is further accelerating market development. In addition, increasing implementation of multimodal AI technologies across healthcare operations is transforming the way providers process and interpret complex clinical information. As healthcare organizations continue generating massive volumes of structured and unstructured medical data, the need for scalable AI-powered platforms capable of delivering accurate insights, workflow automation, and data-driven decision-making continues to strengthen the long-term outlook for the healthcare LLM and foundation model market.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$2.4 Billion
Forecast Value$27.7 Billion
CAGR27.7%

The healthcare LLM and foundation model market comprises advanced artificial intelligence technologies, including large language models, vision foundation models, multimodal foundation models, and biological and genomic foundation models developed to process, interpret, analyze, and generate healthcare-related information. These technologies support a broad range of applications, including clinical documentation, patient engagement, healthcare analytics, medical imaging, clinical decision support, medical coding, genomics research, and drug discovery. Continuous growth in healthcare data generated from clinical records, imaging systems, genomic databases, and other healthcare sources is driving wider adoption of these intelligent solutions. Healthcare organizations are increasingly integrating AI-driven platforms to streamline documentation, optimize administrative workflows, strengthen clinical decision-making, improve coding accuracy, and enhance operational performance while reducing physician workload. At the same time, pharmaceutical and biotechnology organizations are expanding the use of foundation models to improve research efficiency, accelerate therapeutic development, enhance biomarker analysis, and support clinical development activities.

The large language models (LLMs) segment accounted for a 61.2% share in 2025, supported by increasing demand for AI-powered documentation platforms and workflow automation technologies across healthcare organizations. Growing implementation of healthcare-focused language models enables providers to automate clinical documentation, summarize patient records, streamline coding processes, and reduce administrative complexity. These capabilities improve productivity, enhance documentation quality, and allow healthcare professionals to dedicate more time to patient care while minimizing operational inefficiencies associated with manual documentation processes.

The pharmaceutical and biotechnology companies segment is projected to grow at a CAGR of 28.5% throughout 2035. Market growth within this segment is supported by increasing adoption of biological and genomic foundation models to accelerate drug development, improve target discovery, strengthen biomarker research, optimize molecular design processes, and enhance clinical trial efficiency. The expanding application of artificial intelligence throughout research and development activities continues to improve productivity while reducing development timelines across the pharmaceutical and biotechnology industries.

North America Healthcare LLM and Foundation Model Market held a 42.5% share in 2025. Regional growth is supported by advanced healthcare infrastructure, widespread adoption of electronic health record systems, and continued investments in artificial intelligence technologies. Strong digital healthcare transformation initiatives and increasing implementation of AI-powered platforms across hospitals, healthcare networks, and research organizations continue to support market expansion. Growing adoption of intelligent solutions for clinical documentation, patient engagement, healthcare analytics, medical imaging, and clinical decision support is further strengthening the region's leadership position throughout the forecast period.

Key Players in the Global Healthcare LLM and Foundation Model Market include Microsoft, Tempus AI, Orbita, BenevolentAI, OpenAI, Amazon Web Services, Hyro, Abridge, NVIDIA, Google, Paige AI, Anthropic, Suki AI, Elsevier, Isomorphic Labs, Nabla, Aidoc, Viz.ai, Ambience Healthcare, Hippocratic AI, Insilico Medicine, Recursion Pharmaceuticals. Companies operating in the healthcare LLM and foundation model market are strengthening their competitive position through continuous investments in artificial intelligence innovation, healthcare-specific model development, and strategic collaborations with healthcare providers, research organizations, and life sciences companies. Market participants are expanding their product portfolios by introducing specialized AI solutions that improve clinical workflows, automate documentation, and enhance decision support capabilities. Organizations are also investing heavily in cloud-based infrastructure, data security, regulatory compliance, and scalable deployment models to meet the evolving needs of healthcare institutions. In addition, companies are prioritizing research and development to improve model accuracy, multimodal capabilities, and interoperability with existing healthcare systems. Geographic expansion, strategic acquisitions, long-term technology partnerships, and continuous platform enhancements remain key initiatives for strengthening market presence and maintaining a competitive advantage.

Product Code: 16367

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Model type trends
    • 2.2.3 Deployment mode trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for clinical documentation automation
      • 3.2.1.2 Accelerating adoption of AI in drug discovery & genomics research
      • 3.2.1.3 Expansion of value-based care models driving patient engagement AI
      • 3.2.1.4 Growing healthcare data volumes enabling larger and more accurate foundation models
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Data privacy, HIPAA compliance challenges
      • 3.2.2.2 High compute and operational costs for large-scale model deployment
    • 3.2.3 Market opportunities
      • 3.2.3.1 Multimodal AI integration across diagnostics, pathology & genomics
      • 3.2.3.2 Expansion into underserved healthcare markets via low-cost cloud deployment
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 MEA
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Pricing trend analysis (Driven by primary research)
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Impact of AI and Generative AI on the market (Driven by primary research)
  • 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Model Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Large language models (LLMs)
    • 5.2.1 Clinical and documentation LLMs
    • 5.2.2 Patient engagement LLMs
    • 5.2.3 Biomedical research LLMs
  • 5.3 Vision foundation models
  • 5.4 Multimodal foundation models
  • 5.5 Biological and genomic foundation models

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cloud-based
  • 6.3 On-premise

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Clinical documentation
  • 7.3 Medical imaging
  • 7.4 Drug discovery and development
  • 7.5 Patient engagement
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Pharmaceutical and biotechnology companies
  • 8.4 Payers
  • 8.5 Research institutions
  • 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abridge
  • 10.2 Aidoc
  • 10.3 Amazon Web Services
  • 10.4 Ambience Healthcare
  • 10.5 Anthropic
  • 10.6 BenevolentAI
  • 10.7 Elsevier
  • 10.8 Google
  • 10.9 Hippocratic AI
  • 10.10 Hyro
  • 10.11 Insilico Medicine
  • 10.12 Isomorphic Labs
  • 10.13 Microsoft
  • 10.14 Nabla
  • 10.15 NVIDIA
  • 10.16 OpenAI
  • 10.17 Orbita
  • 10.18 Paige AI
  • 10.19 Recursion Pharmaceuticals
  • 10.20 Suki AI
  • 10.21 Tempus AI
  • 10.22 Viz.ai
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!